Invention Grant
- Patent Title: Fused heterocyclic compounds as peptidase inhibitors
- Patent Title (中): 稠合杂环化合物作为肽酶抑制剂
-
Application No.: US10523531Application Date: 2003-08-07
-
Publication No.: US07547710B2Publication Date: 2009-06-16
- Inventor: Satoru Oi , Hironobu Maezaki , Koji Ikedou
- Applicant: Satoru Oi , Hironobu Maezaki , Koji Ikedou
- Applicant Address: JP Osaka
- Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee Address: JP Osaka
- Agency: Wenderoth, Lind & Ponack, L.L.P.
- Priority: JP2002-231950 20020808; JP2003-51575 20030227
- International Application: PCT/JP03/10054 WO 20030807
- International Announcement: WO2004/014860 WO 20040219
- Main IPC: A61K31/47
- IPC: A61K31/47 ; C07D215/12

Abstract:
A compound represented by the formula wherein ring A is an optionally substituted 5- to 10-membered aromatic ring; R1 and R2 are the same or different and each is an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group; X and Y are the same or different and each is a bound, —O—, —S—, —SO—, —SO?2#191- or —NR3— (R3 is a hydrogen atom or an optionally substituted hydrocarbon group); and L is a divalent hydrocarbon group, or a salt thereof shows a superior peptidase-inhibitory activity and is useful as a prophylactic or therapeutic agent of diabetes and the like.
Public/Granted literature
- US20060135530A1 Fused heterocyclic compounds Public/Granted day:2006-06-22
Information query